Learning from the 2015/16 flu campaign highlighted that monitoring of ongoing performance was difficult due to the manual collation of vaccination forms and a separate audit process that had been introduced to capture staff who received their vacciantion at their GP.
To improve this for the 2016/17 flu campaign the flu steering committee, chaired by the deputy chief nurse, agreed to look at an alternative method of capturing and reporting flu vaccinations that took place and reduce the burden of administrative work. After conversations with ICT we decided to develop an app to capture the flu vaccination information.
Open access. The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting.
Background
Gypsies, Travellers and Roma (referred to as Travellers) are less likely to access health services, including immunisation. To improve immunisation rates, we need to understand what helps and hinders individuals in these communities in taking up immunisations.
Aims
(1) Investigate the barriers to and facilitators of acceptability and uptake of immunisations among six Traveller communities across four UK cities; and (2) identify possible interventions to increase uptake of immunisations in these Traveller communities that could be tested in a subsequent feasibility study.
This edition of Vaccine Update contains:
new resources for the seasonal flu programme;
vaccine coverage;
update on the HPV for MSM pilot;
vaccine supply information
The NHS Digital annual report NHS Immunisation Statistics, England, 2015-16 includes coverage statistics on routine childhood vaccinations, which are offered to all children up to the age of five.2
The statistics in this report are derived from data collected by Public Health England, and are used to inform government policy on immunisation and to assess the delivery of different immunisations nationally.
The statistics also support initiatives such as national and regional catch-up programmes for specific immunisations.
This guidance has been produced for the early years sector to assist staff and childminders and answers the most frequently asked questions regarding the nasal spray flu vaccination being offered to children in this age group.
School leavers, particularly those going to university or college this month, are being strongly encouraged to get vaccinated against meningococcal disease after figures released today (Monday 19 September) showed less than a fifth of young people have received the vaccine so far this year.
This leaflet is aimed at children with learning difficulties who are offered the nasal flu vaccination. It provides easy to read advice on:
the flu virus and why you need the vaccine;
signs and symptoms of flu;
What are the effects on their patients of giving influenza vaccination to healthcare workers who care for people aged 60 or older living in long-term care institutions?
Background The UK Department of Health recommends annual influenza vaccination for healthcare workers, but uptake remains low. For staff, there is uncertainty about the rationale for vaccination and evidence underpinning the recommendation.
Objectives To clarify the rationale, and evidence base, for influenza vaccination of healthcare workers from the occupational health, employer and patient safety perspectives. Open Access Article
The user guide provides NHS England Local Teams and Screening and Immunisation Teams (SITs) with detailed guidance on how to submit data for the MenACWY and Td/IPV Vaccine Coverage Collection 2015 to 2016 Local Authority Annual Survey, via the ImmForm web-based system provided by PHE.
This patient group direction (PGD) template is to support the pneumococcal polysaccharide vaccine (PPV) vaccination programme. It is valid from 1 September 2016 to 31 August 2018.
Open access. The BCG vaccine is administered to protect against tuberculosis, but studies suggest there may also be non-specific beneficial effects upon the infant immune system, reducing early non-targeted infections and atopic diseases. The present randomised trial tested the hypothesis that BCG vaccination at birth would reduce early childhood hospitalisation in Denmark, a high-income setting.